News:

Willkommen im Notebookcheck.com Forum! Hier können sie über alle unsere Artikel und allgemein über Notebook relevante Dinge disuktieren. Viel Spass!

Main Menu

Post reply

The message has the following error or errors that must be corrected before continuing:
Warning: this topic has not been posted in for at least 120 days.
Unless you're sure you want to reply, please consider starting a new topic.
Other options
Verification:
Please leave this box empty:

Shortcuts: ALT+S post or ALT+P preview

Topic summary

Posted by Redaktion
 - November 26, 2024, 16:44:55
Expected with high hopes by all those affected by Alzheimer's and investors alike, the Phase 3 trial of Cassava Sciences' proprietary small molecule Simufilam failed to deliver the anticipated results. As a direct consequence, the company's shares dropped from around $26 to less than $4, with no comeback yet.

https://www.notebookcheck.net/Alzheimer-s-drug-Simufilam-fails-to-meet-trial-expectations-Cassava-Sciences-stock-takes-major-hit.923489.0.html